James Grossweiner, M.D.
Dermatology Physician in Naperville, Illinois.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 15,011 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
James Grossweiner, M.D. reported a CMS MIPS final score of 91.4/100 - above the 83.5 national average - and filed 732 Medicare Part D claims in 2024.
- 91.4/100
- MIPS score · +8 vs avg
- 732
- Part D claims, 2024
- 95%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about James Grossweiner, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1437114907), first enumerated 04/19/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 732 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 91.4/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- State context
State board disciplinary context
Illinois statewide board action statistics are published annually — these figures describe aggregate state activity, not James Grossweiner, M.D.'s individual license status. Verify directly with the state medical board.
Source: IDFPR annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1437114907 · Dermatology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ABOVE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1437114907
- ENUM-LEGACY 2006
- TAX-MID 15K Dermatology Physician
- MIPS-ABOVE 91.4/100
- RX-LIGHT 732
- BOOK-LIGHT 584 in Illinois
- PHOTO-FINISH Oyetewa Asempa, MD · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Oyetewa Asempa, …
Oyetewa Asempa, MD
91.3 MIPS pts
- Jennifer Ranario…
Jennifer Ranario, MD, MBA.
91.3 MIPS pts
- Theodore Rosen, …
Theodore Rosen, MD
91.3 MIPS pts
- Grossweiner · th…
Grossweiner · this provider
91.4 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
James Grossweiner, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
91 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where James Grossweiner, M.D. sits
This provider among dermatology physician peers
Across the 5,700 dermatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, James Grossweiner, M.D. writes more Part D claims than 53% of them and scores higher on MIPS quality than 56% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one dermatology physician peer from a representative sample of 60; the gold marker is James Grossweiner, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
James Grossweiner, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about James Grossweiner, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Illinois
How Dermatology Physician compares to other specialties among Illinois providers
Dermatology Physician ranks #62 among Illinois's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the Illinois provider total, by primary NUCC taxonomy. The highlighted bar is Dermatology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
James Grossweiner, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 91.4/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Dermatology Physician US NPIs
91.4/100 MIPS final score - 7.9 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Dermatology Physician. Quality dim: 82.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1437114907 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/19/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm James Grossweiner, M.D.'s current license status, disciplinary history, and board certifications with the Illinois Department of Financial and Professional Regulation in Illinois before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1437114907 is the unique 10-digit identifier CMS uses to link Grossweiner across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
License & disciplinary context - Illinois IDFPR 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 - they are NOT specific to James Grossweiner, M.D.. To verify James Grossweiner, M.D.'s current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
5% brand-name claims vs 95% generic, on 732 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 849.733
- Total Day Supply
- 20,513
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $53K
- Generic Drug Cost
- $24K
- Antibiotic Claims
- 52
Patient Demographics
- Average Patient Age
- 75.6 years
- Avg HCC Risk Score
- 1.01
- Gender Split
- 41% female / 59% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What James Grossweiner, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Triamcinolone Acet…
Triamcinolone Acetonide
72 claims
- Mometasone Furoate
Mometasone Furoate
56 claims
- Fluocinonide
Fluocinonide
45 claims
- Clindamycin Phosph…
Clindamycin Phosphate
44 claims
- Desonide
Desonide
44 claims
- Metronidazole
Metronidazole
44 claims
- Clotrimazole
Clotrimazole
37 claims
- Mupirocin
Mupirocin
37 claims
| Drug | Claims |
|---|---|
| Triamcinolone Acetonide | 72 |
| Mometasone Furoate | 56 |
| Fluocinonide | 45 |
| Clindamycin Phosphate | 44 |
| Desonide | 44 |
| Metronidazole | 44 |
| Clotrimazole | 37 |
| Mupirocin | 37 |
| Doxycycline Hyclate | 30 |
| Econazole Nitrate | 27 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How James Grossweiner, M.D. fits within the Dermatology Physician landscape nationally.
James Grossweiner, M.D.'s 732 claims are below the specialty average of 799.
Nationwide Dermatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Grossweiner, both outside Illinois so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (91.4 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Dermatology Physician Providers in Illinois
Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as Grossweiner.
One of 584 Dermatology Physician providers enrolled in Illinois, 5 are shown here.
Compare Dermatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is James Grossweiner, M.D.'s specialty? ▼
How much does James Grossweiner, M.D. prescribe under Medicare Part D? ▼
What is James Grossweiner, M.D.'s Medicare quality score? ▼
Where is James Grossweiner, M.D. located? ▼
What is James Grossweiner, M.D.'s NPI number? ▼
Does James Grossweiner, M.D. prescribe more brand-name or generic drugs? ▼
How many Dermatology Physician providers are there in the US? ▼
What drugs does James Grossweiner, M.D. prescribe most often? ▼
Does James Grossweiner, M.D. accept Medicare? ▼
How can I verify James Grossweiner, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.